Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Dextromethorphan Stories

Home’s Medicine Cabinet Likely Candidate For Teen Drug Abuse
2012-10-30 11:41:50

Lawrence LeBlond for redOrbit.com - Your Universe Online It seems many adolescents are always finding innovative ways to get hold of drugs. With tighter crackdowns on alcohol and tobacco sales and the fight against illicit drugs, today´s youth are looking toward a much simpler source to get their fix: the home medicine cabinet. Researchers Keith King and Rebecca Vidourek, from the University of Cincinnati, have found, in a new study, that adolescent males are at a higher risk of...

2012-10-01 10:26:21

Educational efforts in over 50 locations nationwide raise awareness about teen medicine abuse WASHINGTON, Oct. 1, 2012 /PRNewswire-USNewswire/ -- The Community Anti-Drug Coalitions of America (CADCA) and the Consumer Healthcare Products Association (CHPA) are mobilizing communities through National Medicine Abuse Awareness Month to stop prescription and over-the-counter (OTC) medicine abuse one community at a time. Each October, CADCA and CHPA team up for National Medicine Abuse...

2012-09-20 14:23:49

FIRESTONE, Colo., Sept. 20, 2012 /PRNewswire/ -- September is National Honey Month, and this year, according to the Centers for Disease Control and Prevention estimates, 346,000 babies in the United States will celebrate their first birthday this month.(1) Why are these two facts related? Research findings have uncovered widespread confusion surrounding the age when babies can eat honey. Through educational outreach, the National Honey Board (NHB) aims to dispel honey...

2012-09-20 06:31:46

ALISO VIEJO, Calif., Sept. 20, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced several business updates. The highlights are being provided in connection with the company's presentation today at the UBS Global Life Sciences Conference in New York City. Highlights include: Exceeding 10,000 total NUEDEXTA® prescriptions for the month of August. NUEDEXTA prescriptions of 10,710 in August represent 9% growth over the month of July. August monthly...

2012-09-04 02:29:42

ALISO VIEJO, Calif., Sept. 4, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the enrollment of the first patient in study AVR-131. The study is a Phase II clinical trial investigating the use of AVP-923 for the treatment of agitation in patients with Alzheimer's disease. "Alzheimer's disease can cause a person to exhibit marked behavioral changes that are difficult for caregivers to manage. These symptoms can include agitation, hostility, anger, and...

2012-09-04 02:29:34

SALT LAKE CITY, Sept. 4, 2012 /PRNewswire/ -- Zarbee's, the fastest-growing cough remedy in the country, today announced the launch of its new line of over-the-counter extra strength all natural cough products for adults and children 12 years and up. The new extra strength products will supplement the existing line of Zarbee's original cough products currently available for children 12 months and up. The new range will make all natural Zarbee's the #1 drug-free cough remedy for the entire...

2012-08-27 02:25:23

ALLEGAN, Mich. and MONMOUTH JUNCTION, N.J., Aug. 27, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) and Tris Pharma, Inc. today announced the commercial launch of a major new store brand product. The new product is equivalent to Delsym® extended-release oral liquid suspension containing dextromethorphan polistirex and will be marketed under major U.S. retailer and wholesalers' store brands or own label brands. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )...

2012-08-03 02:24:14

ALISO VIEJO, Calif., Aug. 3, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) announced today that an additional patent covering Avanir's NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) product has been listed in the U.S. Food and Drug Administration's (FDA) Orange Book. The Orange Book listing requires an Abbreviated New Drug Application (ANDA) applicant, seeking FDA approval for a generic version of NUEDEXTA prior to expiration of the patent, to notify Avanir...

2012-07-11 10:23:47

CHPA commends U.S. Sens. Casey (D-PA) and Murkowski (R-AK) for introducing bill prohibiting the sale of OTC cough medicines containing dextromethorphan to minors WASHINGTON, July 11, 2012 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauds U.S. Sens. Bob Casey (D-PA) and Lisa Murkowski (R-AK) for introducing legislation to help combat teen cough medicine abuse. The Preventing Abuse of Cough Treatments (PACT) Act of 2012 would prohibit the sale...

2012-05-31 02:25:47

MONMOUTH JUNCTION, N.J., May 31, 2012 /PRNewswire/ -- Tris Pharma, a technology driven specialty pharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved the first-ever generic to Delsym®, an extended-release oral liquid suspension containing dextromethorphan polistirex. Delsym was approved in 1982 and there has never been any generic alternative approved until now. Tris has pioneered the delivery of drugs in taste-neutral, extended release...